Correlation Between PharmaEngine and Synmosa Biopharma

Can any of the company-specific risk be diversified away by investing in both PharmaEngine and Synmosa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PharmaEngine and Synmosa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PharmaEngine and Synmosa Biopharma, you can compare the effects of market volatilities on PharmaEngine and Synmosa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PharmaEngine with a short position of Synmosa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of PharmaEngine and Synmosa Biopharma.

Diversification Opportunities for PharmaEngine and Synmosa Biopharma

-0.27

Correlation Coefficient

PharmaEngine  Synmosa Biopharma

Very good diversification

The 3 months correlation between PharmaEngine and Synmosa is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding PharmaEngine and Synmosa Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synmosa Biopharma and PharmaEngine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PharmaEngine are associated (or correlated) with Synmosa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synmosa Biopharma has no effect on the direction of PharmaEngine i.e., PharmaEngine and Synmosa Biopharma go up and down completely randomly.

Pair Corralation between PharmaEngine and Synmosa Biopharma

Assuming the 90 days trading horizon PharmaEngine is expected to generate 3.2 times more return on investment than Synmosa Biopharma. However, PharmaEngine is 3.2 times more volatile than Synmosa Biopharma. It trades about 0.06 of its potential returns per unit of risk. Synmosa Biopharma is currently generating about -0.27 per unit of risk. If you would invest  8,270  in PharmaEngine on September 15, 2024 and sell it today you would earn a total of  610.00  from holding PharmaEngine or generate 7.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

PharmaEngine  vs.  Synmosa Biopharma

PharmaEngine

Risk-Adjusted Performance

4 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in PharmaEngine are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, PharmaEngine may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Synmosa Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Synmosa Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with PharmaEngine and Synmosa Biopharma

The main advantage of trading using opposite PharmaEngine and Synmosa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PharmaEngine position performs unexpectedly, Synmosa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synmosa Biopharma will offset losses from the drop in Synmosa Biopharma's long position.

The idea behind PharmaEngine and Synmosa Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.